Chakraborty, Sandip N <br/><br/>
Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia.  [electronic resource] 

 -  Genes & cancer  May 2016 
 - 201-208 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1947-6019 
<br/><br/><label>Standard No.: </label>10.18632/genesandcancer.111  doi